Pfizer to Buy US Drug Co. for $14b
World Economy

Pfizer to Buy US Drug Co. for $14b

Pfizer is in advanced talks to acquire US cancer drug company Medivation for close to $14 billion, as it seeks to boost its oncology portfolio, a person familiar with the matter said, Reuters reported. Pfizer has so far prevailed in the auction for Medivation and could announce a deal as early as Monday, though the negotiations could still fall apart at the last minute, the person said. Pfizer and Medivation declined to comment. The Financial Times first reported on Pfizer nearing a deal for Medivation earlier on Sunday.


Short URL : http://goo.gl/fkuVtL
  1. http://goo.gl/QHbsBv
  • http://goo.gl/4dsBZD
  • http://goo.gl/QvksoJ
  • http://goo.gl/4FdaUj
  • http://goo.gl/DpGE1k

You can also read ...

India is too poor to grow without exporting.
A trade war would bring forward the next financial crisis...
Turkey’s January industrial output rose an annual 12%.
The International Monetary Fund on Thursday revised up its...
Online searches for “bitcoin” fell 82% from December highs.
Suddenly, Bitcoin seems a bit boring. It might be hard to...
Global consumer confidence Primary Index in March has risen to 50.6, tying the record high set in January 2018.
Simmering fears of a global trade war; an embarrassing...
MSS Market in ASEAN Shows 22.3% Growth
The Managed Security Services market in ASEAN continued its...
Nippon Steel seeks a sharper edge in specialty products.
Nippon Steel & Sumitomo Metal will buy Swedish counterpart...
EBRD’s First Lebanon Deal
The European Bank for Reconstruction and Development has made...
Singapore Exports Fall
Singapore’s key non-oil domestic exports unexpectedly declined...